National Bank of Canada’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63M | Buy |
285,285
+10,293
| +4% | +$94.9K | ﹤0.01% | 880 |
|
|
2025
Q1 | $2.36M | Buy |
274,992
+273,992
| +27,399% | +$2.35M | ﹤0.01% | 854 |
|
|
2024
Q4 | $10.7K | Hold |
1,000
| – | – | ﹤0.01% | 1942 |
|
|
2024
Q3 | $5.68K | Sell |
1,000
-22,500
| -96% | -$128K | ﹤0.01% | 1994 |
|
|
2024
Q2 | $96.6K | Hold |
23,500
| – | – | ﹤0.01% | 1355 |
|
|
2024
Q1 | $89.5K | Buy |
23,500
+22,487
| +2,220% | +$85.7K | ﹤0.01% | 1399 |
|
|
2023
Q4 | $6.12K | Hold |
1,013
| – | – | ﹤0.01% | 2082 |
|
|
2023
Q3 | $6.44K | Hold |
1,013
| – | – | ﹤0.01% | 2078 |
|
|
2023
Q2 | $8.23K | Sell |
1,013
-350
| -26% | -$2.84K | ﹤0.01% | 2064 |
|
|
2023
Q1 | $11.7K | Hold |
1,363
| – | – | ﹤0.01% | 1960 |
|
|
2022
Q4 | $12.6K | Sell |
1,363
-22,163
| -94% | -$205K | ﹤0.01% | 1953 |
|
|
2022
Q3 | $241K | Hold |
23,526
| – | – | ﹤0.01% | 1171 |
|
|
2022
Q2 | $235K | Hold |
23,526
| – | – | ﹤0.01% | 1192 |
|
|
2022
Q1 | $289K | Hold |
23,526
| – | – | ﹤0.01% | 1207 |
|
|
2021
Q4 | $408K | Buy |
+23,526
| New | +$408K | ﹤0.01% | 1120 |
|